Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome reduces effectiveness of hair loss treatment.

A quick method was developed to detect banned substances in urine for doping control.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.

Scalp microinfusion with dutasteride is a safe and promising treatment for male hair loss.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Dexamethasone effectively normalizes elevated steroid levels in girls with premature adrenarche.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Dutasteride does not seem to change rat spermatogenesis or oxidative stress.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

The treatment improved hair growth and was well-received without side effects.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

New methods efficiently isolate dermal papilla cells from hair follicles, preserving their characteristics better than traditional methods.

Testosterone raises blood pressure and changes kidney protein levels.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Dutasteride may protect the brain in early Parkinson's disease.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

The method effectively detects MeT and TP in dried blood spots after cream application.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

SHPro® improved urinary symptoms and erectile function in men and is safe.